Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 2Dermatologic 1

Conditions

Melanoma 5Uveal Melanoma 1Skin Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Carcinoma, Merkel Cell 1Burkitt Lymphoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 42fludarabine phosphate 37Cyclophosphamide 36Mycophenolic Acid 28Whole-Body Irradiation 26Cyclosporine 25Busulfan 25Tacrolimus 22Antilymphocyte Serum 21Methotrexate 16Filgrastim 16Etoposide 15Methylprednisolone 13Melphalan 13Radiotherapy 12Flow Cytometry 11Psychiatric Rehabilitation 10Therapeutics 9Rituximab 9Polymerase Chain Reaction 8Bortezomib 8Gemcitabine 7Cord Blood Stem Cell Transplantation 7sargramostim 6Vorinostat 6Sirolimus 6tanespimycin 5Transplantation 5Thiotepa 5Carboplatin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × oblimersen × Dermatologic × Clear all
NCT00060112 2013-01-25

Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma

National Cancer Institute (NCI)

Phase 1 Terminated
15 enrolled
DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡